Cubist Systematic Strategies, LLC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,226,363
+62.1%
24,246
+22.6%
0.01%
+80.0%
Q1 2023$756,707
-88.0%
19,778
-82.9%
0.01%
-86.5%
Q4 2022$6,328,523
+58.6%
115,484
-1.4%
0.04%
+68.2%
Q3 2022$3,990,000
+1989.0%
117,175
+478.8%
0.02%
+2100.0%
Q2 2022$191,000
+69.0%
20,243
+154.1%
0.00%0.0%
Q1 2022$113,000
+205.4%
7,966
+356.0%
0.00%
Q4 2021$37,000
-43.9%
1,747
-40.9%
0.00%
-100.0%
Q3 2021$66,000
-72.3%
2,958
-69.2%
0.00%
-66.7%
Q2 2021$238,000
+35.2%
9,613
+40.8%
0.00%
+50.0%
Q4 2020$176,000
+183.9%
6,829
+241.4%
0.00%
+100.0%
Q3 2020$62,000
+244.4%
2,000
+177.8%
0.00%
Q2 2020$18,000
-50.0%
720
-57.8%
0.00%
-100.0%
Q1 2020$36,000
+56.5%
1,707
+62.7%
0.00%
Q4 2019$23,000
-61.0%
1,049
-59.7%
0.00%
-100.0%
Q3 2019$59,000
-32.2%
2,603
-42.9%
0.00%
-50.0%
Q2 2019$87,0004,5600.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders